loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1997_057___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Aventis Pharma Deutschland GmbH Frankfurt Am Main DE (1)

    filter

    01 Protirelin (1)

    filter

    01 France (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Aventis Pharma Deutschland GmbH Fra...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Protirelin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1997-057 - Rev 00
    Expired
    Chemical and TSE
    2004-05-25
    2009-05-25
    1144
    Sanofi Company Banner

    Iran Expo

    Not Confirmed

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-057 - Rev 00 of Aventis Pharma Deutschland Gmbh Frankfurt Am Main De

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-057 - Rev 00 of Aventis Pharma Deutschland Gmbh Frankfurt Am Main De 1

    20

    Aventis Pharma Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    One of their significant offerings is Protirelin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R1-CEP 1997-057 - Rev 00

    This Chemical and TSE Type CEP, issued on May 25, 2004, remains in force until May 25, 2009, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1144 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY